Scientific Sessions 2024  /  EHJ and Circulation: Advances in 2024  /  The Year in Cardiometabolic Diseases
Logo

American Heart Association

  15
  0

Final ID:

The Year in Cardiometabolic Diseases

  • Verma, Subodh  ( ST MICHAELS HOSPITAL , Toronto , Ontario , Canada )
  • Consentino, Francesco  ( Karolinska Institutet , Stockholm , Sweden )
  • Mcguire, Darren  ( UT Southwestern , Dallas , Texas , United States )
    • Author Disclosures:
    Subodh Verma: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Amarin (Speaker & Consultant):Active (exists now) ; Other (please indicate in the box next to the company name):Sanofi (Speaker & Consultant):Active (exists now) ; Other (please indicate in the box next to the company name):S & L Solutions Event Management Inc. (Speaker & Consultant):Active (exists now) ; Other (please indicate in the box next to the company name):PhaseBio (Speaker & Consultant):Active (exists now) ; Other (please indicate in the box next to the company name):Pfizer (Speaker & Consultant):Active (exists now) ; Other (please indicate in the box next to the company name):Novo Nordisk (Speaker & Consultant):Active (exists now) ; Other (please indicate in the box next to the company name):Novartis (Speaker & Consultant):Active (exists now) ; Other (please indicate in the box next to the company name):Janssen (Speaker & Consultant):Active (exists now) ; Other (please indicate in the box next to the company name):HLS Therapeutics (Speaker & Consultant):Active (exists now) ; Other (please indicate in the box next to the company name):Eli Lilly (Speaker & Consultant):Active (exists now) ; Other (please indicate in the box next to the company name):Canadian Medical and Surgical Knowledge Translation Research Group (Speaker & Consultant):Active (exists now) ; Research Funding (PI or named investigator):Boehringer Ingelheim (Speaker & Consultant):Active (exists now) ; Research Funding (PI or named investigator):Bayer (Speaker & Consultant):Active (exists now) ; Other (please indicate in the box next to the company name):AstraZeneca (Speaker & Consultant):Active (exists now) ; Other (please indicate in the box next to the company name):Amgen (Speaker & Consultant):Active (exists now) | Francesco Consentino: DO have relevant financial relationships ; Speaker:Novo Nordisk:Past (completed) ; Advisor:Pfizer:Past (completed) ; Speaker:Pfizer:Past (completed) ; Speaker:MSD:Past (completed) ; Speaker:BMS:Past (completed) ; Speaker:Berlin Chemie:Past (completed) | Darren McGuire: DO have relevant financial relationships ; Researcher:Novo Nordisk:Active (exists now) ; Consultant:Amgen:Active (exists now) ; Consultant:Intercept:Active (exists now) ; Consultant:Altimmune:Active (exists now) ; Consultant:Lexicon:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:NovoNordisk:Active (exists now) ; Consultant:Boehringer Ingelheim:Active (exists now) ; Consultant:Lilly USA:Active (exists now) ; Researcher:Esperion:Past (completed) ; Researcher:AstraZeneca:Past (completed) ; Researcher:NewAmsterdam:Active (exists now) ; Researcher:Boehringer Ingelheim:Active (exists now) ; Researcher:Pfizer:Active (exists now) ; Researcher:Lilly USA:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

EHJ and Circulation: Advances in 2024

Sunday, 11/17/2024 , 03:30PM - 04:45PM

Cardiovascular Seminar

More abstracts on this topic:
The Year in Heart Failure

Schiattarella Gabriele, Zieroth Shelley

The Year in Cardiovascular Imaging

Bucciarelli-ducci Chiara, Delgado Victoria

More abstracts from these authors:
Discussant: SELECT

Mcguire Darren, Neeland Ian

Will Future Trials Help Us SURPASS Our Understanding of Diabetes Management?

Taub Pam, Green Jennifer, Mcguire Darren

You have to be authorized to contact abstract author. Please, Login
Not Available